Correlation Between GlaxoSmithKline PLC and 756109BK9

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and 756109BK9 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and 756109BK9 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and O 31 15 DEC 29, you can compare the effects of market volatilities on GlaxoSmithKline PLC and 756109BK9 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of 756109BK9. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and 756109BK9.

Diversification Opportunities for GlaxoSmithKline PLC and 756109BK9

0.83
  Correlation Coefficient

Very poor diversification

The 3 months correlation between GlaxoSmithKline and 756109BK9 is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and O 31 15 DEC 29 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 756109BK9 and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with 756109BK9. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 756109BK9 has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and 756109BK9 go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and 756109BK9

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 2.41 times more return on investment than 756109BK9. However, GlaxoSmithKline PLC is 2.41 times more volatile than O 31 15 DEC 29. It trades about 0.0 of its potential returns per unit of risk. O 31 15 DEC 29 is currently generating about -0.01 per unit of risk. If you would invest  3,429  in GlaxoSmithKline PLC ADR on August 24, 2024 and sell it today you would lose (59.00) from holding GlaxoSmithKline PLC ADR or give up 1.72% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy98.4%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  O 31 15 DEC 29

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
756109BK9 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days O 31 15 DEC 29 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for O 31 15 DEC 29 investors.

GlaxoSmithKline PLC and 756109BK9 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and 756109BK9

The main advantage of trading using opposite GlaxoSmithKline PLC and 756109BK9 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, 756109BK9 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 756109BK9 will offset losses from the drop in 756109BK9's long position.
The idea behind GlaxoSmithKline PLC ADR and O 31 15 DEC 29 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments